Literature DB >> 10820208

Regulation of tyrosine hydroxylase activity and phosphorylation at Ser(19) and Ser(40) via activation of glutamate NMDA receptors in rat striatum.

N Lindgren1, Z Q Xu, M Lindskog, M Herrera-Marschitz, M Goiny, J Haycock, M Goldstein, T Hökfelt, G Fisone.   

Abstract

The activity of tyrosine hydroxylase, the rate-limiting enzyme in the biosynthesis of dopamine, is stimulated by phosphorylation. In this study, we examined the effects of activation of NMDA receptors on the state of phosphorylation and activity of tyrosine hydroxylase in rat striatal slices. NMDA produced a time-and concentration-dependent increase in the levels of phospho-Ser(19)-tyrosine hydroxylase in nigrostriatal nerve terminals. This increase was not associated with any changes in the basal activity of tyrosine hydroxylase, measured as DOPA accumulation. Forskolin, an activator of adenylyl cyclase, stimulated tyrosine hydroxylase phosphorylation at Ser(40) and caused a significant increase in DOPA accumulation. NMDA reduced forskolin-mediated increases in both Ser(40) phosphorylation and DOPA accumulation. In addition, NMDA reduced the increase in phospho-Ser(40)-tyrosine hydroxylase produced by okadaic acid, an inhibitor of protein phosphatase 1 and 2A, but not by a cyclic AMP analogue, 8-bromo-cyclic AMP. These results indicate that, in the striatum, glutamate decreases tyrosine hydroxylase phosphorylation at Ser(40) via activation of NMDA receptors by reducing cyclic AMP production. They also provide a mechanism for the demonstrated ability of NMDA to decrease tyrosine hydroxylase activity and dopamine synthesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10820208     DOI: 10.1046/j.1471-4159.2000.0742470.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  22 in total

Review 1.  Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder.

Authors:  Rong Chen; Mark J Ferris; Shiyu Wang
Journal:  Pharmacol Ther       Date:  2020-05-27       Impact factor: 12.310

2.  Traumatic brain injury reduces striatal tyrosine hydroxylase activity and potassium-evoked dopamine release in rats.

Authors:  Samuel S Shin; Eric R Bray; Cathy Q Zhang; C Edward Dixon
Journal:  Brain Res       Date:  2010-11-01       Impact factor: 3.252

3.  Docosahexaenoic acid protects motor function and increases dopamine synthesis in a rat model of Parkinson's disease via mechanisms associated with increased protein kinase activity in the striatum.

Authors:  Neha Milind Chitre; Bo Jarrett Wood; Azizi Ray; Nader H Moniri; Kevin Sean Murnane
Journal:  Neuropharmacology       Date:  2020-01-27       Impact factor: 5.250

4.  Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors.

Authors:  Andrea Anzalone; José E Lizardi-Ortiz; Maria Ramos; Claudia De Mei; F Woodward Hopf; Ciro Iaccarino; Briac Halbout; Jacob Jacobsen; Chisato Kinoshita; Marc Welter; Marc G Caron; Antonello Bonci; David Sulzer; Emiliana Borrelli
Journal:  J Neurosci       Date:  2012-06-27       Impact factor: 6.167

5.  Acrolein-mediated alpha-synuclein pathology involvement in the early post-injury pathogenesis of mild blast-induced Parkinsonian neurodegeneration.

Authors:  Glen Acosta; Nicholas Race; Seth Herr; Joseph Fernandez; Jonathan Tang; Edmond Rogers; Riyi Shi
Journal:  Mol Cell Neurosci       Date:  2019-06-12       Impact factor: 4.314

6.  Chronic methylphenidate treatment enhances striatal dopamine neurotransmission after experimental traumatic brain injury.

Authors:  Amy K Wagner; Laura L Drewencki; Xiangbai Chen; F Ryan Santos; Amina S Khan; Rashed Harun; Gonzalo E Torres; Adrian C Michael; C Edward Dixon
Journal:  J Neurochem       Date:  2008-12-10       Impact factor: 5.372

7.  Comprehensive profiling of dopamine regulation in substantia nigra and ventral tegmental area.

Authors:  Michael F Salvatore; Brandon S Pruett; Charles Dempsey; Victoria Fields
Journal:  J Vis Exp       Date:  2012-08-10       Impact factor: 1.355

8.  Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson's model.

Authors:  Tanya Chotibut; Richard W Davis; Jennifer C Arnold; Zachary Frenchek; Shawn Gurwara; Vimala Bondada; James W Geddes; Michael F Salvatore
Journal:  Mol Neurobiol       Date:  2013-12-03       Impact factor: 5.590

9.  Preserved dopaminergic homeostasis and dopamine-related behaviour in hemizygous TH-Cre mice.

Authors:  Annika H Runegaard; Kathrine L Jensen; Ciarán M Fitzpatrick; Ditte Dencker; Pia Weikop; Ulrik Gether; Mattias Rickhag
Journal:  Eur J Neurosci       Date:  2016-08-22       Impact factor: 3.386

10.  Catecholamine synthesis and metabolism in the central nervous system of mice lacking alpha-adrenoceptor subtypes.

Authors:  M A Vieira-Coelho; M P Serrão; J Afonso; C E Pinto; E Moura
Journal:  Br J Pharmacol       Date:  2009-08-24       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.